TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia

Cytokine receptor-like factor 2 B-cell acute lymphoblastic leukemia (CRLF2 B-ALL) is a high-risk subtype characterized by CRLF2 overexpression with poor survival rates in children and adults. CRLF2 and interleukin-7 receptor alpha (IL-7Rα) form a receptor for the cytokine thymic stromal lymphopoieti...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkashgari, Hossam R., Ruiz-Jimenez, Caleb, Stoian, Cornelia, Coats, Jacqueline S., Baez, Ineavely, Chirshev, Evgeny, Martinez, Shannalee R., Dovat, Sinisa, Francis-Boyle, Olivia L., Casiano, Carlos A., Payne, Kimberly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820664/
https://www.ncbi.nlm.nih.gov/pubmed/36613920
http://dx.doi.org/10.3390/ijms24010474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820664/
https://www.ncbi.nlm.nih.gov/pubmed/36613920
http://dx.doi.org/10.3390/ijms24010474

Ejemplares similares